Differential effects of synthetic sphingosine derivatives on melanoma cell motility, growth, adhesion and invasion in vitro

Clinical and Experimental Metastasis

Volumn 14, Issue 6, 1996, Pages 477-489

  Helige, Christine ^a   Smolle, Josef ^a   Fink Puches, Regina ^a   Hofmann Wellenhof, Rainer ^a   Hartmann, Esther ^a   Bär, Thomas ^b   Schmidt, Richard R ^b   Tritthart, Helmut A ^a  

^a UNIVERSITY OF GRAZ   (Austria)

^b UNIVERSITY OF KONSTANZ   (Germany)

Author keywords

glycosphingolipids; invasion; melanoma; motility; proliferation

Indexed keywords

GLYCOSPHINGOLIPID; SPHINGOSINE DERIVATIVE;

ANIMAL CELL; ANIMAL TISSUE; ARTICLE; CANCER GROWTH; CANCER INVASION; CELL ADHESION; CELL MOTILITY; CHICK EMBRYO; EMBRYO; IMMUNOCYTOCHEMISTRY; IN VITRO STUDY; MELANOMA; METASTASIS; NONHUMAN;

ACTINS; ANIMALS; CELL DIVISION; CELL MOVEMENT; CHICK EMBRYO; COLLAGEN; DOSE-RESPONSE RELATIONSHIP, DRUG; DRUG COMBINATIONS; LAMININ; MELANOMA; MICE; NEOPLASM INVASIVENESS; PROTEOGLYCANS; SPHEROIDS, CELLULAR; SPHINGOSINE;

EID: 0030443101     PISSN: 02620898     EISSN: None     Source Type: Journal    
DOI: 10.1007/BF00115108     Document Type: Article

References (46)

1. Sträuli P and Haemmerli G, 1984, The role of cancer cell motility in invasion. Cancer Metastasis Rev, 3, 127-141.
2. Liotta LA, 1986, Tumor invasion and metastases - role of the extracellular matrix: Rhoads memorial award lecture. Cancer Res, 46, 1-7.
3. Zimmermann A and Keller HU, 1987, Locomotion of tumor cells as an element of invasion and metastasis. Biomed Pharmacother, 41, 337-44.
4. Marcel MM, De Baetselier P and Van Roy FM, eds, 1991, Mechanisms of Invasion and Metastasis. Boca Raton: CRC Press Inc.
5. 3 subunit with tumor progress. Cancer Res, 50, 6757-64.
6. 3 integrin in human melanoma cell invasion. Proc Nat Acad Sci USA, 89, 1557-61.
7. Van Echten G, Birk R, Brenner-Weiss G, Schmidt RR and Sandoff K, 1990, Modulation of sphingolipid biosynthesis in primary cultured neurons by long-chain bases. J Biol Chem, 265, 9333-9.
8. Kadowaki H, Evans JE, Rys-Sikora KE and Koff RS, 1990. Effect of differentiation and cell density on glycosphingolipid class and molecular species composition of mouse neuroblastoma NB2 cells. J Neurochem, 54, 2125-37.
9. Hanqing M, Avrova N, Mansson JE, Molin K and Svennerholm L, 1986, Gangliosides and neutral glycosphingolipids of normal tissue and oat cell carcinoma of human lung. Biochim Biophys Acta, 878, 360-70.
10. Siddiqui B, Buehler J, De Gregorio MW and Macher BA, 1984, Differential expression of ganglioside GD3 by human leukocytes and leukemia cells. Cancer Res, 44, 5262-5.
11. Thurin J, Thurin M, Herlyn M, et al., 1986, GD2 ganglioside biosynthesis is a distinct biochemical event in human melanoma tumor progression. FEBS Lett, 208, 17-22.
12. Hanisch FG, Solter J, Jansen V, Locher A, Peter-Katalinic J and Uhlenbruck G, 1990, Glycosphingolipid expression on murine L1-fibrosarcoma cells: analysis of clonal in vivo and in vitro selected sublines with different lung colonisation potential. Br J Cancer, 61, 813-20.
13. Sakakibara K, Momoi T, Uchida T and Nagai Y, 1981, Evidence for association of glycosphingolipid with a colchicine-sensitive microtubule-like cytoskeletal structure of cultured cells. Nature, 293, 76-9.
14. Gillard BK, Thurmon LT and Marcus DM, 1992, Association of glycosphingolipids with intermediate filaments of mesenchymal, epithelial, glial, and muscle cells. Cell Motil Cytoskel, 21, 255-71.
15. Laine RA and Hakomori S, 1973, Incorporation of exogeneous glycosphingolipids in plasma membranes of cultured hamster cells and concurrent change of growth behavior. Biochem Biophys Res Commun, 54, 1039-45.
16. Cheresh DA, Pierschbacher MD, Herzig MA and Mujoo K, 1986, Disialogangliosides GD2 and GD3 are involved in the attachment of human melanoma and neuroblastoma cells to extracellular matrix proteins. J Cell Biol, 102, 688-96.
17. Radin NS and Inokuchi JI, 1988, Glucosphingolipids as sites of action in the chemotherapy of cancer. Biochem Pharmacol, 37, 2879-86.
18. Inokuchi JI and Radin NS, 1987, Antitumor activity via inhibition of glycosphingolipid biosynthesis. Cancer Lett, 38, 23-30.
19. Hellström I, Brankovan V and Hellström KE, 1985, Strong antitumor activities of IgG3 antibodies to human melanoma-associated gangliosides. Proc Nat Acad Sci USA, 82, 1499-502.
20. Houghton AN, Mintzer D, Cordon-Cardo C, et al., 1985, Mouse monoclonal IgG3 antibody detecting GD3 ganglioside: a phase I trial in patients with malignant melanoma. Proc Nat Acad Sci USA, 82, 1242-6.
21. Tsuchida T, Saxton RE, Morton DL and Irie RF, 1987, Gangliosides of human melanoma. J Nat Cancer Inst, 78, 45-54.
22. Alessandri G, Filippeschi S, Sinibaldi P, et al., 1987, Influence of gangliosides on primary and metastatic neoplastic growth in human and murine cells. Cancer Res, 47, 4243-7.
23. Talmadge JE and Fidler IJ, 1982, Enhanced metastatic potential of tumor cells harvested from spontaneous metastases of heterogenous murine tumors. J Nat Cancer Inst, 69, 975-80.
24. Strom SC and Michalopoulos G, 1982, Collagen as a substrate for cell growth and differentiation. Meth Enzymol, 82, 544-55.
25. Hofmann-Wellenhof R, Smolle J, Helige C, Gottlieb G, Tritthart HA and Kerl H, 1994, Quantitative assessment of melanoma single cell motility in vitro. Exp Dermatol, 3, 219-26.
26. Mareel MM, Kint J and Meyvisch C, 1979, Methods of study of the invasion of malignant C3H-mouse fibroblasts into embryonic chick heart in vitro. Archiv Pathol Anat Physiol Klin Med B: Cell Pathol, 30, 95-111.
27. Smolle J, Helige C and Tritthart HA, 1992, An image analysis and statistical evaluation program for the assessment of tumor cell invasion in vitro. Analyt Cell Pathol, 4, 49-57.
28. Albini A, Iwamoto Y, Kleinman HK, et al., 1987, A rapid in vitro assay for quantitating the invasive potential of tumor cells. Cancer Res, 47, 3239-45.
29. Bortz J, 1985, Lehrbuch der Statistik für Sozialwissenschaftler, Springer Verlag: Berlin.
30. Storme G and Mareel MM, 1980, Effect of anticancer agents on directional migration of malignant C3H-mouse fibroblastic cells in vitro. Cancer Res, 40, 943-48.
31. 4 cells in vitro. Arch Geschwulstforsch, 51, 45-50.
32. Sadahira Y, Zheng M, Ruan F, Hakomori S and Igarashi Y, 1994. Sphingosine-1-phosphate inhibits extracellular matrix protein-induced haptotactic motility but not adhesion of B16 mouse melanoma cells. FEBS Lett, 340, 99-103.
33. Alessandri G, Raju KS and Gullino PM, 1986, Interaction of gangliosides with fibronectin in the mobilization of capillary endothelium: Possible influence on metastasis. Invas Metast, 6, 145-65.
34. Inokuchi JI, Jimbo M, Momosaki K, Shimeno N, Nagamatsu A and Radin NS, 1990, Inhibition of experimental metastasis of murine Lewis lung carcinoma by an inhibitor of glucosylceramide synthase and its possible mechanism of action. Cancer Res, 50, 6731-7.
35. Pokorná E, Jordan PW, O'Neil CH, Gilbert CS and Vesely P, 1994, Actin cytoskeleton and motility in rat sarcoma cell populations with different metastatic potential. Cell Motil Cytoskel, 28, 25-33.
36. Morton DM and Tchao R, 1994, Regulation of motility and cytoskeletal organization of rat bladder carcinoma cells by cyclic AMP. Cell Motil Cytoskel, 29, 375-82.
37. Inokuchi JI, Momosaki K, Shimeno H, Nagamatsu A and Radin NS, 1989, Effects of D-threo-PDMP, an inhibitor of glucosylceramide synthase, on expression of cell surface glycolipid antigen and binding to adhesive proteins by B16 melanoma cells. J Cell Physiol, 141, 573-83.
38. Igarashi Y, Kitamura K, Toyokuni T, et al., 1990, A specific enhancing effect of N,N-dimethylsphingosine on epidermal growth factor receptor autophosphorylation. Demonstration of its endogeneous occurrence (and the virtual absence of unsubstituted sphingosine) in human epidermoid carcinoma A431 cells. J Biol Chem, 265, 5385-9.
39. M1 and sphingolipid breakdown products in cellular proliferation and signal transduction pathways. Glycoconjugate J, 9, 110-17.
40. Zhang H, Desai NN, Olivera A, Seki T, Brooker G and Spiegel S, 1991, Sphingosine-1-phosphate, a novel lipid, involved in cellular proliferation. J Cell Biol, 114, 155-67.
41. 1 Bundesrepublik Deutschland, 22.11.1990.
42. Mandon EC, Van Echten G, Birk R, Schmidt RR and Sandhoff K, 1991, Sphingolipid biosynthesis in cultured neurons. Down-regulation of serine palmitoyltransferase by sphingoid bases. Eur J Biochem, 198, 667-74.
43. Hannun YA and Bell RM, 1987. Lysosphingolipids inhibit protein kinase C: Implications for the sphingolipidoses. Science, 235, 670-4.
44. Kreutter D, Kim JYH, Goldenring JR, et al., 1987, Regulation of protein kinase C activity by gangliosides. J Biol Chem, 262, 1633-7.
45. Igarashi Y, Hakomori S, Toyokuni T, et al., 1989, Effect of chemically well-defined sphingosine and its N-methyl derivatives on protein kinase C and src kinase activities. Biochemistry, 28, 6796-800.
46. Helige C, Smolle J, Zellnig G, Fink-Puches R, Kerl H and Tritthart HA, 1993, Effect of dequalinium on K1735-M2 melanoma cell growth, directional migration and invasion in vitro. Eur J Cancer, 29A, 124-8.